Updates are available Correction dated 2018-01-16

Article History

Received: 30 September 2017

Accepted: 22 November 2017

First Online: 4 December 2017

Change Date: 16 January 2018

Change Type: Correction

Change Details: Owing to an oversight by the authors, Figure 2 in this article was not the version intended for publication. The correct Figure 2, reproduced here, features footnote symbols and Figure 2b includes three studies as described in the main text.

Compliance with ethical standards

:

: TF is supported by the Japan Society for the Promotion of Science (JSPS) and has received a grant from JSPS. This study was funded in part by Grant-in-Aid for JSPS Research Fellow JP16J10320 to TF. SMB is supported by a Canada Research Chair in Critical Care Nephrology and is a steering committee member of the EUPHRATES trial. He has consulted and received speaking fees from Baxter Healthcare Corp. TAF has received lecture fees from Eli Lilly, Janssen, Meiji, Mitsubishi-Tanabe, MSD, and Pfizer. He has received royalties from Igaku-Shoin and Nihon Bunka Kagaku-sha publishers. He has received research support from Mitsubishi-Tanabe and Mochida. KD received lecture fees from Asahi Kasei Medical Crop, Baxter Healthcare Corp., and Toray Medical Corp. JLV, DP, RB, and CR were engaged in the clinical trials included in this review, and provided some of the data not reported in their published papers. None of these funding organizations have contributed to the study design; collection, management, analysis, and interpretation of data; writing of the report, or the decision to submit the report for publication. Toray Industries provided some of the data included in this review, as noted in the body of the article.

: The authors declare that they have no conflicts of interest.